Andre C. Ferreira
Nova Iguacu, RJ 26275580, Brazil
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications
Severe influenza infection is associated with inflammatory programmed cell death in infected macrophages.
Journal: Frontiers in cellular and infection microbiology
Published: October 11, 2022
Commercially Available Flavonols Are Better SARS-CoV-2 Inhibitors than Isoflavone and Flavones.
Journal: Viruses
Published: June 10, 2022
Preclinical development of kinetin as a safe error-prone SARS-CoV-2 antiviral able to attenuate virus-induced inflammation.
Journal: Nature communications
Published: April 14, 2022
Atazanavir Is a Competitive Inhibitor of SARS-CoV-2 Mpro, Impairing Variants Replication In Vitro and In Vivo.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: November 29, 2021
Unlike Chloroquine, Mefloquine Inhibits SARS-CoV-2 Infection in Physiologically Relevant Cells.
Journal: Viruses
Published: November 29, 2021
Simvastatin Downregulates the SARS-CoV-2-Induced Inflammatory Response and Impairs Viral Infection Through Disruption of Lipid Rafts.
Journal: Frontiers in immunology
Published: November 22, 2021
VIP plasma levels associate with survival in severe COVID-19 patients, correlating with protective effects in SARS-CoV-2-infected cells.
Journal: Journal of leukocyte biology
Published: November 18, 2021
Correction: SARS-CoV-2 engages inflammasome and pyroptosis in human primary monocytes.
Journal: Cell death discovery
Published: May 20, 2021
SARS-CoV-2 engages inflammasome and pyroptosis in human primary monocytes.
Journal: Cell death discovery
Published: December 07, 2020
Lipid droplets fuel SARS-CoV-2 replication and production of inflammatory mediators.
Journal: PLoS pathogens
Published: November 04, 2020
Last Updated: 09/26/2026